Novartis’ Exforge To Launch By End Of June
Launch timeframe for the combination of firm’s Diovan and Pfizer’s Norvasc is a few months earlier than previously expected due to recent invalidation of Norvasc patent.
Launch timeframe for the combination of firm’s Diovan and Pfizer’s Norvasc is a few months earlier than previously expected due to recent invalidation of Norvasc patent.